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quantify the reproducibility of the eye immobilization system CT 
scans were co-registered using rigid 6D skull registration. With 
the scans co-registered x, y and z displacement of the lens/optic 
nerve insertion were measured manually. From these 
displacements, a 3D vector was calculated. 
Results: Thirty-four patients were identified, having been 
treated from October 2010 to September 2015. Thirty-nine co-
registrations were performed using 75 scans (2-3 scans per 
patient). The mean displacements of lens and optic nerve 
insertion were 0.1 mm and 0.0 mm — confirming that there was 
no systemic shift from planning to treatment. The median 3D 
displacements (absolute value) of lens and nerve insertion were 
0.8 and 0.7 mm (SD 0.5 and 0.6 mm). Ninety-eight percent of 3D 
displacements were below 2 mm (maximum 2.4 mm). Following 
this analysis, we have not changed our GTV to PTV margin of 2-3 
mm as it is also meant to account for uncertainties in planning 
MRI to CT registration, skull tracking as well as contouring 
variability. 
Conclusions: We have found our stereotactic eye immobilization 
system to be highly accurate (< 1 mm) and free of systematic 
error. 
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Purpose: To evaluate the role of volumetric modulated arc 
therapy (VMAT) combined with flattening filter free (FFF) beam 
delivery in lung stereotactic body radiotherapy (SBRT).  
Methods and Materials: Ninety-eight Stage I lung cancer cases 
treated with SBRT were included. Retrospectively, single arc, 6 
MV VMAT with FFF and flattened filed (FF) beam plans were 
generated using the identical optimization criteria with Acuros 
XB dose computation algorithm. Optimization constraints 
included target dose ratio of 50% prescription isodose volume to 
target (R50%) and maximal dose at 2 cm from the target (D2cm). 
Study parameters including the number of monitor units (MUs), 
mean target dose, conformality number (CN) and heterogeneity 
index (HI) of the target, R50%, D2cm, and mean dose to normal 
tissues were determined and compared for the two delivery 
modes. A paired matched t-test was used to compare the 
difference. The effect of tumour, patient and treatment mode 
(FFF versus FF) on the difference of MUs obtained from the two 
delivery systems was statistically determined using linear 
regression analyses. 
Results: FFF beams required 6.9% (range -3.4 to 15.6%) more MUs 
and resulted in slightly higher values for mean target dose, R50% 
and D2cm (all p < 0.0001) compared to FF beams. CN, HI of target 
and mean dose to the normal body were similar between the two 
plans. Logistic regression analysis confirmed that VMAT with FFF 
mode, not the tumour or patient specific parameters, caused the 
increase in MUs compared to FF beam delivery (p = 0.043).  
Conclusions: In lung SBRT, using VMAT with FFF beam required 
7% more MUs compared to a VMAT with FF beam plan and 
provided similar target coverage. The low leakage dose 
advantage of FFF delivery is offset by the increased number of 
MU. The only advantage available to the FFF beams is their 
estimated faster delivery.  
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Purpose: Deep inspiration breath hold (DIBH) is an established 
technique to reduce heart and lung dose during radiation therapy 
for left-sided breast cancer. The visually monitored DIBH method 
(VM-DIBH)is a low-cost technique that employs coincident in-
room lasers and skin marks to reproduce the breath hold level 
(BHL) achieved at CT simulation. The purpose of this study was 
to quantify inter-fraction BHL variability, and to perform a 
process review and revision to streamline and improve the 
current VM-DIBH process at our cancer centre. Specific 
guidelines, workflows, and tolerances were established to 
improve daily treatment accuracy, reduce systematic errors and 
inter-fractional respiratory variability, and mitigate potential 
breath hold reproducibility issues prior to treatment. 
Methods and Materials: BH measurements were collected for 55 
left-sided breast patients at the time of simulation and 
treatment; to determine population inter-fraction BHL 
differences. The BHL was determined by measuring the anterior-
posterior displacement of the lateral tattoo on the affected side 
between free breathing and BH. Inter-fraction BHL differences 
were quantified to establish a baseline for improvement and a 
BHL tolerance for treatment to reduce the respiratory variation 
within the VM-DIBH technique. Respiratory reproducibility 
assessment guidelines to be applied during simulation were 
developed and validated on a cohort of 12 left-sided breast 
patients to determine their candidacy for VM-DIBH. This cohort 
of patients was treated using the new BHL tolerance and was 
compared to 12 patients treated using the original DIBH process. 
To assess acceptability of the process change, a 12 question 
survey was completed by Radiation Therapists prior to and 
following implementation. 
Results: A 3 mm BHL tolerance was chosen for this pilot study as 
an achievable goal with respiratory coaching based on the 
population data collected (n = 55). Sixty percent of patients had 
a BHL variability of ≤ 5 mm with 36% of patients ≤ 3 mm. The 
mean and standard deviation was 5 mm and 3 mm respectively. 
Tolerances greater than 3 mm were deemed too large when 
combined with setup errors. One hundred percent of patients 
treated with the new DIBH process in place (n = 12) were able to 
achieve a breath hold within the 3 mm tolerance. The increased 
respiratory reproducibility achieved with the BHL tolerance 
yielded decreased setup variation in the motion vectors 
influenced by respiration (longitudinal and vertical directions). 
When localizing the isocentre on day 1 of treatment, the 
frequency of required couch shifts decreased by 17% in both the 
anterior-posterior and superior-inferior directions. The new 
process was well received based on the radiation therapists 
surveyed. 
Conclusions: The new streamlined DIBH process improved 
workflows, decreased BHL variability and received positive 
feedback from staff. Respiratory inter-fractional errors were 
reduced, which may lead to reduced systematic setup errors. 
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Purpose: Breast boost to the tumour bed following whole breast 
radiotherapy (RT) in breast-conserving therapy can reduce local 
recurrence. The aim of this study was to identify appropriate and 
reliable surrogates to optimize cone beam computed tomography 
(CBCT) image registration for breast boost patients to reduce 
inter-user variability.  
Methods and Materials: Daily localization CBCT images are 
acquired and any positional discrepancies corrected prior to 
three-field conformal breast boost treatment delivery. Under 
ethics approval, patients receiving breast boost RT between 
October and December 2014 were included in this retrospective 
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analysis. Patients were categorized into three groups based on 
their cavity visibility on CT: C1 (indistinct or no visible cavity); 
C2 (moderately visible cavity with indistinct borders); and C3 
(highly visible cavity). Three observers manually registered the 
CBCTs for each patient utilizing two methods and materials: 
matching the ipsilateral breast/chest wall and lung interface as 
the target surrogate, and direct registration to the cavity. 
Krippendorff’s alpha was used to assess agreement between the 
two methods. Root mean square (RMS) was calculated to assess 
the difference between observers.  
Results: Thirty breast boost patients, 10 in each cavity 
visualization category, were included for analysis. A total of 150 
CBCT images were analyzed by each observer. Registration to the 
ipsilateral chestwall/breast reported a median RMS error of 
0.1989 between observers. Direct registration to the cavity 
resulted in a median RMS error of 0.1784 between observers. The 
Krippendorff’s alpha for ipsilateral chestwall/breast registration 
in C1, C2 and C3 patients in the left-right (LR), cranio-caudal 
(CC), and anterior-posterior (AP) directions were: 0.8,0.84, 0.9; 
0.81, 0.72, 0.55; and 0.78, 0.6, 0.52, respectively. The 
Krippendorff’s alpha for direct cavity registration in C1, C2 and 
C3 patients in the LR, CC, and AP directions were: 0.72, 0.64, 
0.84; 0.86, 0.72, 0.62; and 0.75, 0.6, 0.58, respectively. The 
ranksum difference between registration methods was p = 
0.1538, with variation reported between cavity visualization 
categories (C1, p = 0.8903, C2, p = 0.0257, C3, p = 0.9450). 
Conclusions:  Image registration to the ipsilateral breast/chest 
wall and lung interface for breast boost RT was more consistent 
than direct registration to the cavity, resulting in lower inter-
observer variability for breast boost IGRT. Varying visibility of 
the post-operative tumour bed on CBCT images limits direct 
registration to the breast cavity. 
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Purpose: Whole brain radiotherapy (WBRT) has been effectively 
used for palliative treatment of brain metastases, and for 
prophylactic treatment in cancers shown to commonly 
metastasize to the brain. A retrospective investigation was 
completed to compare the traditional whole brain osseous-based 
field placement technique to a volumetric based technique with 
respect to clinical target volume (CTV) coverage, planning target 
volume (PTV) coverage, and the optic lens Dmax. 
Methods and Materials: This study included 47 patients treated 
with field-based WBRT in an aqua plastic mask at the Simcoe 
Muskoka Regional Cancer Program between July 2012 and July 
2013. On the 3D CT image, the CTV (brain) was contoured with a 
5 mm PTV margin, a contour-based plan was generated using the 
Multileaf Collimators to conform to the PTV with a 7 mm 
penumbra margin and 5 mm shielding around the optic lens. The 
plan was then normalized using V95% ≥ 99% to PTV with a Dmax 
point dose ≤ 115%. This contour-based plan was then compared 
to the original field-based plan. Descriptive statistics was used 
for analysis. 
Results:  The mean values for the field based plans and the 
contour based plans are as follows. CTV V95%: 99.55%, SD = 0.47% 
compared to 99.96%, SD = 0.08%; PTV V95%: 98.62%, SD = 0.82% 
compared to 99.73%, SD = 0.21%, optic lens Dmax: 3.66 Gy, SD = 
3.09Gy compared to 3.68 Gy, SD = 0.78 Gy. 
Conclusions:  This study demonstrates an increase in CTV V95% 
of 0.41% and PTV V95% of 1.11% with the volumetric based WBRT 
planning technique compared to the traditional osseous field-
based technique. A contour-based WBRT approach ensures 
standardization in generating a plan and eliminates the inter-
operator variability amongst the radiation oncologists, while 
maintaining comparable optic lens Dmax dose.  
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Purpose: Compare dosimetric differences between VMAT plans 
with and without an objective to spare the vagina, to determine 
whether the volume of the vagina that receives 20 (V20 Gy), 30, 
40, 45, or 50 Gy could be reduced. Secondary objectives included 
whether the maximum dose (Dmax) delivered, and the mean 
dose (Dmean) delivered are significantly different between the 
two treatment plans 
Methods and Materials: Ten patients with rectal cancer 
previously treated with 3D conformal radiotherapy were selected 
for this study. All patients received 50.4 Gy in 28 fractions of 
radical neoadjuvant RT for T3, N1-2, low rectal cancers. Two 
VMAT plans were created for each patient; one with an objective 
to spare the vagina and one without. Target coverage and sparing 
of other organs at risk were not compromised between the two 
VMAT plans. Differences in vaginal dose was determined using 
Wilcoxon signed-rank tests. The selected threshold for 
significance was p-value ≤ 0.05/7 using a Bonferroni correction 
for multiple comparisons. 
Results: Significant differences were observed for the median 
Dmax and Dmean doses delivered, and the median V50Gy 
volumes; 52.6 versus 49.6 Gy (p = 0.0051), 49.9 versus 47.8 Gy 
(p = 0.0051), and 47.6 versus 0% (p = 0.0051) respectively. V45 
Gy volumes also appeared different between the two treatment 
plans and would be considered significant at the p-value ≤ 0.05 
threshold, but because the threshold p-value was adjusted using 
the Bonferroni correction, it was no longer significant. The 
dosimetric differences between V20 Gy, V30 Gy, and V40 Gy 
were not significant. 
Conclusions: VMAT planning using an objective to spare the 
vagina can significantly reduce the volume of vagina receiving 50 
Gy, as well as the Dmax and Dmean, without compromising 
target coverage or adjacent organs at risk dose constraints. 
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Purpose: To determine the impact of a process improvement 
project on the Ready-to-Treat to Treatment (RTT-to-RTx) target 
which had been reduced from 90% within four weeks to 90% 
within 2.6 weeks in a nine-linac cancer centre with a pre-project 
RTT-to-Tx interval of 90% within 3.8 weeks.  
Methods and Materials: Using a process improvement 
methodology based on LEAN and Six Sigma principles, the defined 
opportunity goal, was to reduce the RTT-RTx for patients 
receiving RT for breast cancer (25% of the centre’s RT courses) 
by 30% from 3.8 weeks to 2.6 weeks (27 days reduced to 18 days), 
within six months, without negatively impacting other tumour 
groups. The RTT-to-RTx data was reported as three monthly 
rolling averages. The improvement process was structured along 
six components: Define Opportunity, Build Understanding, 
Manage Change, Act to Improve, Sustain Results, and Share 
Learning. To define the opportunity, a six-hour, current state 
process mapping occurred. This demonstrated that the existing 
process had many steps/hand-offs/interruptions/waits without 
much continuous flow. The value stream map showed that there 
was inconsistent use of the RTT date, an average lead time from 
Booking to Treatment of 12-13 working days (18 calendar days), 
and only five to eight hours of value added time. Building 
understanding included presentations to radiation oncology, 
therapist and clerical groups. 
